Together, the present study demonstrates that IL-33 and ST2 are highly expressed by various CNS resident cells, and there was a change of the expression levels and patterns of both molecules in the CNS lesions of MS patients compared with healthy brain tissues. The gene discussed is IL33; the disease is myeloid sarcoma.